Prognostic Significance of Pretreatment NeutrophilLymphocyte Ratio and PlateletLymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma

Abstract EN

It is generally believed that there is correlation between cancer prognosis and pretreatment PLR and NLR.

However, there are limited data about their role in diffuse large B cell lymphoma (DLBCL).

This study aims to determine the prognostic value of pretreatment PLR and NLR for patients who have DLBCL.

The associations between clinical characteristics and NLR and PLR were evaluated among 182 DLBCL patients from January 2005 to June 2016.

The optimal cutoff values for high PLR (⩾150) and NLR (⩾2.32) in prognosis prediction were determined.

The effect of NLR and PLR on survival was evaluated through multivariate Cox regression analysis, univariate analysis, and log-rank test.

According to the evaluation results, patients with high NLR and PLR had significantly shorter OS (P=0.026 and P=0.035) and PFS (P=0.024 and P=0.022) compared with those who have low PLR and NLR.

On multivariate analyses, IPI>2, elevated LDH, and PLR⩾2.32 were prognostic factors for OS and PFS in DLBCL patients.

Therefore, we demonstrated that high PLR and NLR predicted adverse prognostic factors in DLBCL patients.